Germany: Europe’s Go-To Market Changes Rules For High-Risk And Promising Devices
Several recent changes to the German health care system will significantly influence the market access climate for medical device companies working in Europe’s largest market. Do they represent an opportunity or a threat for manufacturers accessing the market?
You may also be interested in...
Only two of eight treatments passed muster under Germany's new NUBs scheme for assessing the benefit of high-risk products for inpatient use. As with the country's outpatient assessment counterpart, industry is pushing for changes.
Germany's introduction of benefit assessments for class IIb and class III medical devices, and the impending EU Medical Device and IVD Regulations will place an unquantified strain on medtech manufacturers in Europe's largest market. But new innovation schemes are adding more dimensions for businesses locally.